Table 2. Change in Process of Care and Outcomes.
| Characteristics | Composite use of treatments | In-hospital mortality | Five-day mortality | |||
|---|---|---|---|---|---|---|
| OR (95% CI) | P valuea | OR (95% CI) | P valuea | OR (95% CI) | P valuea | |
| Years 2011-2015b | 2.06 (1.91-2.23) | <.001 | 0.77 (0.63-0.95) | .01 | 0.80 (0.64-1.00) | .05 |
| Region | ||||||
| Eastern | 1.02 (0.95-1.10) | <.001 | 0.80 (0.62-1.05) | .06 | 0.76 (0.57-1.00) | .04 |
| Central | 0.83 (0.76-0.91) | 0.68 (0.50-0.93) | 0.66 (0.47-0.92) | |||
| Western | 1 [Reference] | 1 [Reference] | 1 [Reference] | |||
| Year × region | ||||||
| 2011-2015b × Eastern | 0.83 (0.76-0.91) | <.001 | 1.04 (0.82-1.32) | .81 | 1.01 (0.78-1.31) | .98 |
| 2011-2015b × Central | 1.05 (0.94-1.16) | 0.97 (0.72-1.30) | 0.98 (0.71-1.36) | |||
| 2011-2015b × Western | 1 [Reference] | 1 [Reference] | 1 [Reference] | |||
Abbreviations: OR, odds ratio.
a
Adjusted for patient characteristics, such as age, sex, current smoker, hypertension, diabetes, dyslipidemia, prior coronary heart disease, prior myocardial infarction, prior stroke, low systolic blood pressure, high heart rate, white blood cell count, kidney dysfunction, cardiac arrest, and cardiogenic shock.
b
Patients in the years 2001-2006 were the reference group.